🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, claiming the corporations concealed alleged dangers that the pain reliever created to children's brain development.

This legal action comes thirty days after Donald Trump promoted an unsubstantiated connection between using acetaminophen - referred to as acetaminophen - throughout gestation and autism in offspring.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "deceived the public by profiting off of pain and marketing drugs regardless of the dangers."

Kenvue says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering numerous people to boost earnings," the attorney general, from the Republican party, stated.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "continuously evaluated the pertinent research and there is no credible data that demonstrates a verified association between using paracetamol and autism spectrum disorder."

Associations representing physicians and healthcare providers agree.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can pose significant medical dangers if ignored.

"In more than two decades of investigation on the consumption of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of acetaminophen in any period of gestation results in neurological conditions in children," the organization commented.

The lawsuit references recent announcements from the Trump administration in claiming the drug is allegedly unsafe.

Recently, Trump caused concern from medical authorities when he instructed women during pregnancy to "fight like hell" not to take acetaminophen when sick.

The US Food and Drug Administration then released a statement that medical professionals should contemplate reducing the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism in children has not been established.

Health Secretary Kennedy, who supervises the FDA, had vowed in April to initiate "comprehensive study program" that would determine the source of autism spectrum disorder in a matter of months.

But specialists advised that finding a sole reason of autism spectrum disorder - considered by experts to be the result of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism is a category of enduring cognitive variation and condition that influences how individuals perceive and relate to the surroundings, and is identified using physician assessments.

In his legal document, the attorney general - who supports Trump who is seeking federal office - asserts Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the evidence" around acetaminophen and autism.

The lawsuit seeks to make the corporations "remove any promotional materials" that asserts acetaminophen is secure for pregnant women.

The Texas lawsuit parallels the complaints of a collection of guardians of children with autism spectrum disorder and ADHD who filed suit against the makers of acetaminophen in recently.

A federal judge threw out the lawsuit, declaring studies from the plaintiffs' authorities was inconclusive.